Arcus Biosciences Stock Price on November 27, 2024
| RCUS Stock | USD 15.81 0.10 0.63% |
Below is the normalized historical share price chart for Arcus Biosciences extending back to March 15, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Arcus Biosciences stands at 15.81, as last reported on the 26th of December, with the highest price reaching 16.08 and the lowest price hitting 15.68 during the day.
If you're considering investing in Arcus Stock, it is important to understand the factors that can impact its price. Currently, Arcus Biosciences is not too volatile. Arcus Biosciences secures Sharpe Ratio (or Efficiency) of 0.029, which signifies that the company had a 0.029% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for Arcus Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcus Biosciences' risk adjusted performance of 0.0263, and Mean Deviation of 2.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.11%.
At this time, Arcus Biosciences' Common Stock is comparatively stable compared to the past year. Capital Stock is likely to gain to about 1.4 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 57.8 M in 2024. . At this time, Arcus Biosciences' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 3.39 in 2024, despite the fact that Price Earnings Ratio is likely to grow to (4.37). Arcus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of March 2018 | 200 Day MA 16.2055 | 50 Day MA 16.3088 | Beta 0.89 |
Arcus |
Sharpe Ratio = 0.029
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | RCUS | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.66 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.11 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Arcus Biosciences is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arcus Biosciences by adding it to a well-diversified portfolio.
Price Book 2.5769 | Enterprise Value Ebitda 3.9599 | Price Sales 5.5359 | Shares Float 51.5 M | Wall Street Target Price 33.2 |
Related Headline
Structure Therapeutics Headline on 27th of November 2024
Why Is Structure Therapeutics Inc. Among the Best Up and Com... by finance.yahoo.com
We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts. In this article, we are going to take a look at where Structure Therapeutics Inc. stands against the other up and coming stocks. Donald Trumps victory in the recent presidential election is expected to encourage companies that
Arcus Biosciences Valuation on November 27, 2024
It is possible to determine the worth of Arcus Biosciences on a given historical date. On November 27, 2024 Arcus was worth 15.77 at the beginning of the trading date compared to the closed value of 15.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arcus Biosciences stock. Still, in general, we apply an absolute valuation method to find Arcus Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arcus Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arcus Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 14.39 | 16.60 | 14.36 | 15.79 | 1,075,124 | |
11/27/2024 | 15.77 | 16.39 | 15.56 | 15.80 | 553,424 |
| 15.76 | 15.85 | 15.41 | 15.44 | 321,542 |
| Backtest Arcus Biosciences | | | Arcus Biosciences History | | | Arcus Biosciences Valuation | Previous | Next |
Arcus Biosciences Trading Date Momentum on November 27, 2024
| On November 29 2024 Arcus Biosciences was traded for 15.44 at the closing time. The top price for the day was 15.85 and the lowest listed price was 15.41 . The trading volume for the day was 321.5 K. The trading history from November 29, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.28% . The overall trading delta against the current closing price is 11.65% . |
Arcus Biosciences Fundamentals Correlations and Trends
By evaluating Arcus Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arcus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Arcus Biosciences Stock history
Arcus Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arcus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arcus Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arcus Biosciences stock prices may prove useful in developing a viable investing in Arcus Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 74 M | 57.8 M | |
| Net Loss | -240.3 M | -228.3 M |
Arcus Biosciences Quarterly Net Working Capital |
|
Arcus Biosciences Stock Technical Analysis
Arcus Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Arcus Biosciences Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
Arcus Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Arcus Biosciences December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Arcus Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arcus Biosciences shares will generate the highest return on investment. By undertsting and applying Arcus Biosciences stock market strength indicators, traders can identify Arcus Biosciences entry and exit signals to maximize returns
Arcus Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Arcus Biosciences' price direction in advance. Along with the technical and fundamental analysis of Arcus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arcus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0263 | |||
| Jensen Alpha | 0.0133 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0102 | |||
| Treynor Ratio | 0.0424 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.